Jamaica Hospital Medical Center is a private, non-profit teaching hospital and emergency facility in the Jamaica neighborhood of Queens, New York City, on the service road of the Van Wyck Expressway at Jamaica Avenue.

During the past decade, Jamaica Hospital Medical Center conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 17 clinical trials were completed, i.e. on average, 113.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 8 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jamaica Hospital Medical Center" #1 sponsor was "Gilead Sciences" with 5 trials, followed by "Jamaica Hospital Medical Center" with 3 trials sponsored, "Major Extremity Trauma Research Consortium" with 3 trials sponsored, "Brigham and Women's Hospital" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jamaica Hospital Medical Center" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator, "Jamaica Hospital Medical Center" with 2 trials as a collaborator, "United States Department of Defense" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator and "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "Jamaica Hospital Medical Center" are "COVID-19" (3 trials), "Coronary Artery Disease" (3 trials), "Bronchiectasis" (2 trials), "COVID-19 Pneumonia" (2 trials) and "Covid19" (2 trials). Many other conditions were trialed in "Jamaica Hospital Medical Center" in a lesser frequency.

Most popular intervention types in "Jamaica Hospital Medical Center" are "Drug" (19 trials), "Other" (5 trials), "Behavioral" (3 trials), "Procedure" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Remdesivir" (3 trials), "AZLI" (2 trials), "Standard of Care" (2 trials) and "ACE-I (lisinopril) or ARB (losartan)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jamaica Hospital Medical Center" are 32 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Jamaica Hospital Medical Center". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Jamaica Hospital Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Jamaica Hospital Medical Center, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".